Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)

BACKGROUND: To evaluate the clinical outcomes of combination of androgen deprivation therapy (ADT), whole pelvic radiotherapy (WPRT), and stereotactic body radiotherapy (SBRT) boost in high-risk prostate cancer patients. METHODS: This prospective phase I/IIa study was conducted between 2016 and 2017...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yeon Joo, Ahn, Hanjong, Kim, Choung-Soo, Kim, Young Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542889/
https://www.ncbi.nlm.nih.gov/pubmed/33032643
http://dx.doi.org/10.1186/s13014-020-01665-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542889/
https://www.ncbi.nlm.nih.gov/pubmed/33032643
http://dx.doi.org/10.1186/s13014-020-01665-6

Ejemplares similares